The interplay between symptoms or complications of SARS‐CoV‐2 in patients with SCD who has anemia at baseline, varying levels of hemoglobin variants such as Hb S, Hb F, iron overload, current or recent exposure to hydroxyurea, other prescription drugs, and underlying lung pathology remains unknown. This evidence concerns the gene GSTM1 and anemia.